Aminocaproic Acid Injection, Solution
Product Images NDC 71872-7359

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Aminocaproic Acid (NDC 71872-7359). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7359.pdp (7359)

This is a product label for Aminocaproic Acid Injection, USP, containing 5g/20mL (250 mg/mL). The medication is intended for intravenous use and must be diluted before administration. The label provides cautionary instructions, dosage information, and storage guidelines. The product is manufactured in Japan and distributed by Hospira Inc. located in Lake Forest, IL, USA. Additional information includes the lot number, expiration date, and required aseptic technique for handling the solution.*

FDA Label Image

7359m.jpg (7359m)

This is a 20mL Single-dose Vial of Aminocaproic Acid Injection, USP, with a concentration of 250 mg/mL. It is sterile and nonpyrogenic, and must be diluted for intravenous use. Each mL contains 250 mg of aminocaproic acid and may contain hydrochloric acid for pH adjustment. For dosage information, refer to the insert provided. Distributed by Hospira, Inc., this product is intended for medical use only.*

FDA Label Image

Hospira Logo (Aminocaproic 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.